Cannabis firm raises stg£25m
GW Pharmaceuticals, which is developing the world's first cannabis-based medicine for pain relief, has raised stg£25m through an initial public offering.
Chief executive Geoffrey Guy will see his paper fortune valued at stg£47m when the company floats on the junior AIM stock market next Thursday.